# FDA 483 - Syed Jamal Mustafa, M.D. - May 31, 2019

Source: https://www.keypedia.com/records/483/syed-jamal-mustafa-md/d2bb2615-afae-455e-8c7e-39af051bf3d7

> FDA 483 for Syed Jamal Mustafa, M.D. on May 31, 2019. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Syed Jamal Mustafa, M.D.
- Inspection Date: 2019-05-31
- Product Type: drugs
- Office Name: Division of Human and Animal Food Operations - West VI
- Summary: The FDA inspected Syed Jamal Mustafa, Principal Investigator, in Bothell, WA, regarding clinical trial conduct. The inspection revealed significant deviations from investigational plans and protocols, including the enrollment of ineligible subjects, delayed reporting of a serious adverse event, and improper administration of investigational product and physical examinations by unqualified personnel. These findings indicate a lack of adherence to established clinical trial regulations and internal procedures.

## Related Officers

- [issuing_officer](https://www.keypedia.com/people/sunitha-k-rajaram/1a0872d4-5e7b-4690-a2be-3877aec25053)

Company: https://www.keypedia.com/companies/syed-jamal-mustafa-md/c8f5c88e-0ead-41d4-aebc-ff075153dc4f

Office: https://www.keypedia.com/offices/division-of-human-and-animal-food-operations-west-vi/6e5a2a08-f464-4979-a759-7b0383370822